These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 446919)

  • 21. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma glucose, insulin and lipids during growth of genetically lean and obese swine.
    Mersmann HJ; Pond WG; Yen JT
    Growth; 1982; 46(3):189-98. PubMed ID: 6757063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.
    Keskin M; Kurtoglu S; Kendirci M; Atabek ME; Yazici C
    Pediatrics; 2005 Apr; 115(4):e500-3. PubMed ID: 15741351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitation of fasting plasma glucose for the diagnosis of diabetes mellitus.
    Taylor R; Zimmet P
    Diabetes Care; 1981; 4(5):556-8. PubMed ID: 7347665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin and glucose responses to glucose injection in fed and fasted obese and lean sheep.
    McCann JP; Ullmann MB; Temple MR; Reimers TJ; Bergman EN
    J Nutr; 1986 Jul; 116(7):1287-97. PubMed ID: 3528428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.
    Maggio AB; Mueller P; Wacker J; Viallon M; Belli DC; Beghetti M; Farpour-Lambert NJ; McLin VA
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):720-6. PubMed ID: 22157928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
    Ehrmann DA; Breda E; Cavaghan MK; Bajramovic S; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in blood insulin levels in obese children during fasting and after oral administration of glucose].
    Krawczuk-Rybakowa M; Urban M; Koćmierska-Grodzka D; Pawłowska D; Pedziński W
    Endokrynol Pol; 1984; 35(2):113-9. PubMed ID: 6378609
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.
    Bergman BC; Cornier MA; Horton TJ; Bessesen DH
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1103-11. PubMed ID: 17684102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects.
    Herranz L; Zapata A; Grande C; Megia A; Pallardo LF
    Horm Metab Res; 1998 Mar; 30(3):141-5. PubMed ID: 9566856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
    Dunaif A; Segal KR; Futterweit W; Dobrjansky A
    Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance.
    Zimmet P; Whitehouse S; Alford F; Chisholm D
    Diabetologia; 1978 Jul; 15(1):23-7. PubMed ID: 680420
    [No Abstract]   [Full Text] [Related]  

  • 37. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
    García Pascual IJ; González Ruiz JM
    An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus.
    Praveen EP; Kulshreshtha B; Khurana ML; Sahoo JP; Gupta N; Kumar G; Dwivedi SN; Ammini AC
    Diabetes Technol Ther; 2010 Sep; 12(9):723-30. PubMed ID: 20707738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leisure time physical activity and insulin resistance in young obese students with hypertension.
    Saito I; Nishino M; Kawabe H; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):915-8. PubMed ID: 1285941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.